{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:14:36Z","timestamp":1792095276155,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10620-025-09431-y","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:13:07Z","timestamp":1759990387000},"page":"838-851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Advancing the Diagnosis and Management of Genetic Cholestatic Liver Disease in Adults"],"prefix":"10.1007","volume":"71","author":[{"given":"Ahmad Basil","family":"Nasir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Alkhouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Kin","family":"Syn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"9431_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000347210","volume":"31","author":"C J\u00fcngst","year":"2013","unstructured":"J\u00fcngst C, Lammert F. Cholestatic liver disease. Dig Dis 2013;31:152\u2013154.","journal-title":"Dig Dis"},{"key":"9431_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0046-8177(70)80002-8","volume":"1","author":"H Popper","year":"1970","unstructured":"Popper H, Schaffner F. Pathophysiology of cholestasis. Hum Pathol 1970;1:1\u201324.","journal-title":"Hum Pathol"},{"key":"9431_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/jgh.13738","volume":"32","author":"G Pollock","year":"2017","unstructured":"Pollock G, Minuk GY. Diagnostic considerations for cholestatic liver disease. J Gastroenterol Hepatol 2017;32:1303\u20131309.","journal-title":"J Gastroenterol Hepatol"},{"key":"9431_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jhep.2017.07.004","volume":"67","author":"C Dr\u00f6ge","year":"2017","unstructured":"Dr\u00f6ge C, Bonus M, et al. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants. J Hepatol 2017;67:1253\u20131264.","journal-title":"J Hepatol"},{"key":"9431_CR5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1872-034X.2009.00499.x","volume":"39","author":"YC Hsu","year":"2009","unstructured":"Hsu YC, Chen\u00a0HL, et al. Adult progressive intrahepatic cholestasis associated with genetic variations in ATP8B1 and ABCB11. Hepatol Res 2009;39:625\u2013631.","journal-title":"Hepatol Res"},{"key":"9431_CR6","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1002\/hep4.2051","volume":"6","author":"JS Nayagam","year":"2022","unstructured":"Nayagam JS,\u00a0Foskett P,\u00a0et al. Clinical phenotype of adult-onset liver disease in patients with variants in ABCB4, ABCB11, and ATP8B1. Hepatol Commun 2022;6:2654\u20132664.","journal-title":"Hepatol Commun"},{"key":"9431_CR7","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1111\/apt.16118","volume":"52","author":"JS Nayagam","year":"2020","unstructured":"Nayagam JS, Williamson C, et al. Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1. Aliment Pharmacol Ther 2020;52:1628\u20131639.","journal-title":"Aliment Pharmacol Ther"},{"key":"9431_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cis.2010.12.002","volume":"165","author":"J Maldonado-Valderrama","year":"2011","unstructured":"Maldonado-Valderrama, Wilde P, J et al. The role of bile salts in digestion. Adv Colloid Interface Sci 2011;165:36\u201346.","journal-title":"Adv Colloid Interface Sci"},{"key":"9431_CR9","first-page":"2313675","volume":"2018","author":"E Sticova","year":"2018","unstructured":"Sticova E, Jirsa M, Paw\u0142owska J. New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications. Can J Gastroenterol Hepatol 2018;2018:2313675.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"9431_CR10","doi-asserted-by":"publisher","first-page":"10046","DOI":"10.1074\/jbc.273.16.10046","volume":"273","author":"T Gerloff","year":"1998","unstructured":"Gerloff T, Stieger B, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998;273:10046\u201310050.","journal-title":"J Biol Chem"},{"key":"9431_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1152\/physrev.00027.2002","volume":"83","author":"M Trauner","year":"2003","unstructured":"Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 2003;83:633\u2013671.","journal-title":"Physiol Rev"},{"key":"9431_CR12","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1002\/j.1460-2075.1987.tb02653.x","volume":"6","author":"AM Van der Bliek","year":"1987","unstructured":"Van der Bliek AM, Baas F, et al. The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. Embo j 1987;6:3325\u20133331.","journal-title":"Embo j"},{"key":"9431_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1159\/000518203","volume":"40","author":"C J\u00fcngst","year":"2022","unstructured":"J\u00fcngst C,\u00a0Justinger\u00a0C, et al. Common ABCB4 and ABCB11 Genotypes Are Associated with Idiopathic Chronic Cholestasis in Adults. Dig Dis 2022;40:489\u2013496.","journal-title":"Dig Dis"},{"key":"9431_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jhep.2012.04.023","volume":"57","author":"S Decock","year":"2012","unstructured":"Decock S, Roelandts R, et al. Cholestasis-induced pruritus treated with ultraviolet B phototherapy: an observational case series study. J Hepatol 2012;57:637\u2013641.","journal-title":"J Hepatol"},{"key":"9431_CR15","doi-asserted-by":"crossref","unstructured":"Scaravaglio M, Ronzoni L, et al., Diagnostic yield of whole exome sequencing in adult-onset cholestatic liver disease. Clin Gastroenterol Hepatol, 2025.","DOI":"10.1016\/j.cgh.2025.07.031"},{"key":"9431_CR16","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.4254\/wjh.v13.i12.2024","volume":"13","author":"V Vinayagamoorthy","year":"2021","unstructured":"Vinayagamoorthy V, Srivastava A, Sarma MS. Newer variants of progressive familial intrahepatic cholestasis. World J Hepatol 2021;13:2024\u20132038.","journal-title":"World J Hepatol"},{"key":"9431_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-4-1","volume":"4","author":"A Davit-Spraul","year":"2009","unstructured":"Davit-Spraul A,\u00a0Gonzales\u00a0E, et al. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis 2009;4:1.","journal-title":"Orphanet J Rare Dis"},{"key":"9431_CR18","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/hep.23158","volume":"50","author":"DE Folmer","year":"2009","unstructured":"Folmer DE,\u00a0Van der Mark VA,\u00a0et al. Differential effects of progressive familial intrahepatic cholestasis type 1 and benign recurrent intrahepatic cholestasis type 1 mutations on canalicular localization of ATP8B1. Hepatology 2009;50:1597\u20131605.","journal-title":"Hepatology"},{"key":"9431_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hep.20285","volume":"40","author":"LW Klomp","year":"2004","unstructured":"Klomp LW, Vargas JC, et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 2004;40:27\u201338.","journal-title":"Hepatology"},{"key":"9431_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/sj.ejhg.5201355","volume":"13","author":"JN Painter","year":"2005","unstructured":"Painter JN, Savander M, et al. Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy. Eur J Hum Genet 2005;13:435\u2013439.","journal-title":"Eur J Hum Genet"},{"key":"9431_CR21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41436-018-0100-y","volume":"20","author":"NT Strande","year":"2018","unstructured":"Strande NT, Brnich SE, et al. Navigating the nuances of clinical sequence variant interpretation in Mendelian disease. Genetics in Medicine 2018;20:918\u2013926.","journal-title":"Genetics in Medicine"},{"key":"9431_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpeds.2021.04.040","volume":"236","author":"A Al-Hussaini","year":"2021","unstructured":"Al-Hussaini A, Lone K, et al. ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations Associated with Cholestasis with Different Phenotypes and Outcomes. J Pediatr 2021;236:113-123.e2.","journal-title":"J Pediatr"},{"key":"9431_CR23","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines on genetic cholestatic liver diseases. J Hepatol, 2024. 81(2): p. 303-325.","DOI":"10.1016\/j.jhep.2024.04.006"},{"key":"9431_CR24","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1053\/gast.2003.50144","volume":"124","author":"JF Lucena","year":"2003","unstructured":"Lucena JF, Herrero\u00a0JI, et al. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 2003;124:1037\u20131042.","journal-title":"Gastroenterology"},{"key":"9431_CR25","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1007\/s10620-022-07416-9","volume":"67","author":"A Sinha","year":"2022","unstructured":"Sinha A, Bhuva M,\u00a0et al. ABCB4 Mutations in Adults Cause a Spectrum Cholestatic Disorder Histologically Distinct from Other Biliary Disease. Dig Dis Sci 2022;67:5551\u20135561.","journal-title":"Dig Dis Sci"},{"key":"9431_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3748\/wjg.v26.i5.550","volume":"26","author":"CS Wei","year":"2020","unstructured":"Wei CS, Becher N, et al. New tight junction protein 2 variant causing progressive familial intrahepatic cholestasis type 4 in adults: A case report. World J Gastroenterol 2020;26:550\u2013561.","journal-title":"World J Gastroenterol"},{"key":"9431_CR27","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00535-017-1423-1","volume":"53","author":"G Vitale","year":"2018","unstructured":"Vitale G, Gitto S,\u00a0et al. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing. J Gastroenterol 2018;53:945\u2013958.","journal-title":"J Gastroenterol"},{"key":"9431_CR28","doi-asserted-by":"publisher","first-page":"11823","DOI":"10.1038\/s41598-017-11626-x","volume":"7","author":"PH Dixon","year":"2017","unstructured":"Dixon PH, Sambrotta M, et al. An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy. Scientific Reports 2017;7:11823.","journal-title":"Scientific Reports"},{"key":"9431_CR29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1053\/j.gastro.2007.05.015","volume":"133","author":"SW Van Mil","year":"2007","unstructured":"Van Mil SW, Milona A,\u00a0et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 2007;133:507\u2013516.","journal-title":"Gastroenterology"},{"key":"9431_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","volume":"73","author":"DBE van Wessel","year":"2020","unstructured":"van Wessel DBE, Thompson RJ, et al. Genotype correlates with the natural history of severe bile salt export pump deficiency. J Hepatol 2020;73:84\u201393.","journal-title":"J Hepatol"},{"key":"9431_CR31","doi-asserted-by":"crossref","unstructured":"Squires, R.H, Ng V, et al., Evaluation of the Pediatric Patient for Liver Transplantation: 2014 Practice Guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology, 2014. 60(1).","DOI":"10.1002\/hep.27191"},{"key":"9431_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2016.517","volume":"112","author":"PY Kwo","year":"2017","unstructured":"Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol 2017;112:18\u201335.","journal-title":"Am J Gastroenterol"},{"key":"9431_CR33","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2019","unstructured":"Lindor KD, Bowlus C, et al. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology 2019;69:394\u2013419.","journal-title":"Hepatology"},{"key":"9431_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/00365521.2017.1422800","volume":"53","author":"L Aamann","year":"2018","unstructured":"Aamann L,\u00a0\u00d8rntoft N,\u00a0et al. Unexplained cholestasis in adults and adolescents: diagnostic benefit of genetic examination. Scand J Gastroenterol 2018;53:305\u2013311.","journal-title":"Scand J Gastroenterol"},{"key":"9431_CR35","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/MPG.0000000000003094","volume":"72","author":"SJ Karpen","year":"2021","unstructured":"Karpen SJ, Kamath B,\u00a0et al. Use of a Comprehensive 66-Gene Cholestasis Sequencing Panel in 2171 Cholestatic Infants, Children, and Young Adults. J Pediatr Gastroenterol Nutr 2021;72:654\u2013660.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9431_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2023.113408","volume":"258","author":"CB Chen","year":"2023","unstructured":"Chen CB, Hsu JS, et al. Combining Panel-Based Next-Generation Sequencing and Exome Sequencing for Genetic Liver Diseases. J Pediatr 2023;258:113408.","journal-title":"J Pediatr"},{"key":"9431_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cld.2022.08.011","volume":"27","author":"R Selim","year":"2023","unstructured":"Selim R, Ahn J. Pruritus in Chronic Liver Disease. Clin Liver Dis 2023;27:47\u201355.","journal-title":"Clin Liver Dis"},{"key":"9431_CR38","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1159\/000360518","volume":"32","author":"AE Kremer","year":"2014","unstructured":"Kremer AE, Bolier R, et al. Advances in pathogenesis and management of pruritus in cholestasis. Dig Dis 2014;32:637\u2013645.","journal-title":"Dig Dis"},{"key":"9431_CR39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/jpn3.12101","volume":"78","author":"R Himes","year":"2024","unstructured":"Himes R, Rosenthal P, et al. Real-world experience of maralixibat in Alagille syndrome: Novel findings outside of clinical trials. J Pediatr Gastroenterol Nutr 2024;78:506\u2013513.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9431_CR40","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S2468-1253(24)00080-3","volume":"9","author":"AG Miethke","year":"2024","unstructured":"Miethke AG, Moukarzel A, et al. Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol 2024;9:620\u2013631.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"9431_CR41","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","volume":"7","author":"RJ Thompson","year":"2022","unstructured":"Thompson RJ, Arnell H, et al. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol 2022;7:830\u2013842.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"9431_CR42","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S2468-1253(24)00074-8","volume":"9","author":"N Ovchinsky","year":"2024","unstructured":"Ovchinsky N, Aumar M, et al. Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial. The Lancet Gastroenterology & Hepatology 2024;9:632\u2013645.","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"9431_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/cpt.3103","volume":"115","author":"F Carre\u00f1o","year":"2024","unstructured":"Carre\u00f1o F, Karatza E, et al. Population Dose-Response-Time Analysis of Itch Reduction and Patient-Reported Tolerability Supports Phase III Dose Selection for Linerixibat. Clin Pharmacol Ther 2024;115:288\u2013298.","journal-title":"Clin Pharmacol Ther"},{"key":"9431_CR44","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.clnu.2023.09.010","volume":"42","author":"S Mancell","year":"2023","unstructured":"Mancell S, Manwani\u00a0K, et al. Medium-chain triglycerides and the impact on fat absorption, growth, nutritional status and clinical outcomes in children with cholestatic liver disease: A scoping review. Clin Nutr 2023;42:2159\u20132172.","journal-title":"Clin Nutr"},{"key":"9431_CR45","unstructured":"Sutton, H., R.J. Sokol, and B.M. Kamath, IBAT inhibitors in pediatric cholestatic liver diseases: Transformation on the horizon? Hepatology, 9900."},{"key":"9431_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jhep.2019.03.021","volume":"71","author":"SJ Aronson","year":"2019","unstructured":"Aronson SJ, Bakker R.S, et al. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice. J Hepatol 2019;71:153\u2013162.","journal-title":"J Hepatol"},{"key":"9431_CR47","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.1038\/s41467-019-13614-3","volume":"10","author":"ND Weber","year":"2019","unstructured":"Weber ND, Odriozola L,\u00a0et al. Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model. Nat Commun 2019;10:5694.","journal-title":"Nat Commun"},{"key":"9431_CR48","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/hep.32441","volume":"76","author":"N Zabaleta","year":"2022","unstructured":"Zabaleta N, Torella L, et al. mRNA and gene editing: Late breaking therapies in liver diseases. Hepatology 2022;76:869\u2013887.","journal-title":"Hepatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09431-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09431-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09431-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:02:38Z","timestamp":1773295358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09431-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["9431"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09431-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}